Objectif Blood is the essential physiological parameter when it comes to assess our health, going from routine check-ups to complextests for infectious diseases. Each step in the process of the blood draw affects the quality of the specimen and is thusimportant for preventing laboratory error, patient injury and even death. E.g. the touch of a finger to verify the location of avein before insertion of the needle increases the chance that a specimen will be contaminated. This can cause false bloodculture results, prolong hospitalization, delay diagnosis and cause unnecessary use of antibiotics.A total of 2,947 sharps injuries involving a source patient infected with a blood borne virus were reported by health careworkers, during 2002-2011 in England, Wales and Northern Ireland. Significant sharps injuries were 67% higher in 2011compared to 2002. Nearly 40% of the injuries occur after use and before the sharp devices are disposed. 41% of the injuriesoccur while sharp devices are used and 15% of injuries during disposal or after it.Every minute, more than 10,000 venipunctures are being performed in the world. However, needles have not changed formore than 150 years. The needle normally produces only transitory mild discomfort. However, from 3.5 to 10% of thepopulation suffer from belonephobia (extreme fear of needles) avoiding healthcare settings.We are developing a needle-free solution which is able to extract, collect and analyse blood in a painless, safe an easy way.Our approach enables monitoring of major global infectious diseases such as HIV, Malaria and Hepatitis which is key for asustainable elimination of such. SmartSyringe represents a breakthrough especially for blood collection in developingcountries. As almost no training is required for proper usage, facilitating diagnostics in areas where there is a lack ofhealthcare professionals. Champ scientifique medical and health scienceshealth sciencesinfectious diseasesmalarianatural sciencesbiological sciencesmicrobiologyvirologymedical and health scienceshealth sciencesinfectious diseasesRNA virusesHIVmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibioticsengineering and technologymedical engineeringmedical laboratory technologylaboratory samples analysis Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Thème(s) EIC-SMEInst-2018-2020 - SME instrument Appel à propositions H2020-EIC-SMEInst-2018-2020 Voir d’autres projets de cet appel Sous appel H2020-SMEInst-2018-2020-1 Régime de financement SME-1 - SME instrument phase 1 Coordinateur QLOUDLAB SA Contribution nette de l'UE € 50 000,00 Adresse GRAND-RUE 68 1095 LUTRY Suisse Voir sur la carte PME L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention. Oui Région Schweiz/Suisse/Svizzera Région lémanique Vaud Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Liens Contacter l’organisation Opens in new window Participation aux programmes de R&I de l'UE Opens in new window Réseau de collaboration HORIZON Opens in new window Coût total € 71 429,00